Shawver Laura 4
4 · ARS Pharmaceuticals, Inc. · Filed Jun 27, 2025
Insider Transaction Report
Form 4
Shawver Laura
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-25+30,000→ 30,000 totalExercise: $17.26Exp: 2035-06-24→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest in full on the earlier of June 25, 2026 or the date of the Issuer's 2026 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.